X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-07 | PG | Procter & Gamble Co | Coombe Gary A | CEO - Grooming | S - Sale+OE | $164.98 | -21,388 | 38,608 | -36% | -$3,528,592 | |||||
| M | 2024-04-30 | CLNN | Clene Inc. | General Resonance LLC | 10% | S - Sale | $0.41 | -26,000 | 15,313,712 | 0% | -$10,564 | |||||
2024-05-07 | BSPK | Bespoke Extracts, Inc. | Feinsod Michael | CEO, 10% | P - Purchase | $0.11 | +3,000 | 2,133,112 | 0% | +$330 | ||||||
| D | 2024-05-07 | RNA | Avidity Biosciences, Inc. | Boyce Sarah | Pres, CEO | S - Sale+OE | $25.54 | -28,000 | 112,117 | -20% | -$715,050 | |||||
2024-05-07 | USNA | Usana Health Sciences Inc | Iiekking G Doug | CFO | S - Sale | $44.76 | -5,198 | 0 | -100% | -$232,677 | ||||||
| D | 2024-05-03 | ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | CFO | S - Sale+OE | $22.50 | -1,000 | 0 | -100% | -$22,500 | |||||
2024-05-03 | ARDX | Ardelyx, Inc. | Grammer Elizabeth A | See Remarks | S - Sale | $9.00 | -45,000 | 267,993 | -14% | -$405,000 | ||||||
2024-05-03 | JAZZ | Jazz Pharmaceuticals Plc | Patil Neena M | EVP, GC | S - Sale | $109.65 | -5,000 | 36,629 | -12% | -$548,250 | ||||||
2024-05-06 | IPSC | Century Therapeutics, Inc. | Russotti Gregory | See Remarks | S - Sale | $3.12 | -5,000 | 385,092 | -1% | -$15,619 | ||||||
2024-05-03 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Finance, Operations | S - Sale | $3.11 | -257 | 317,323 | 0% | -$798 | ||||||
2024-05-03 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Operations Officer | S - Sale | $3.11 | -913 | 137,236 | -1% | -$2,836 | ||||||
| D | 2024-05-06 | CRVS | Corvus Pharmaceuticals, Inc. | Jones William Benton | See Remarks | P - Purchase | $1.73 | +20,000 | 153,773 | +15% | +$34,624 | |||||
| D | 2024-05-06 | CRVS | Corvus Pharmaceuticals, Inc. | Miller Richard A Md | Pres, CEO | P - Purchase | $1.73 | +577,634 | 2,067,753 | +39% | +$1,000,000 | |||||
2024-05-06 | OLMA | Olema Pharmaceuticals, Inc. | Harmon Cyrus | Dir | S - Sale | $10.92 | -5,000 | 928,311 | -1% | -$54,600 | ||||||
2024-05-06 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO | S - Sale | $1.13 | -3,576 | 1,153,697 | 0% | -$4,041 | ||||||
2024-05-03 | IONS | Ionis Pharmaceuticals Inc | Klein Joseph III | Dir | S - Sale | $42.71 | -6,000 | 16,446 | -27% | -$256,277 | ||||||
| D | 2024-05-03 | ARDX | Ardelyx, Inc. | Williams Laura A | Chief Medical Officer | S - Sale+OE | $8.35 | -39,949 | 370,189 | -10% | -$333,574 | |||||
| D | 2024-05-07 | CYTK | Cytokinetics Inc | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $65.11 | -15,547 | 137,056 | -10% | -$1,012,265 | |||||
2024-05-03 | ECL | Ecolab Inc. | Maclennan David | Dir | P - Purchase | $227.37 | +650 | 21,320 | +3% | +$147,788 | ||||||
| DM | 2024-05-03 | UTHR | United Therapeutics Corp | Rothblatt Martine A | CHAIRPERSON, CEO | S - Sale+OE | $259.89 | -7,200 | 130 | -98% | -$1,871,233 | |||||
2024-05-03 | OLPX | Olaplex Holdings, Inc. | Belhumeur Kristi A | SVP of Accounting | S - Sale | $1.68 | -42,480 | 356,665 | -11% | -$71,366 | ||||||
2024-05-06 | DD | Dupont De Nemours, Inc. | Weaver Leland | Pres, Water, Protection | S - Sale | $78.40 | -18,500 | 25,226 | -42% | -$1,450,400 | ||||||
2024-05-03 | ALVR | Allovir, Inc. | Brainard Diana | CEO | S - Sale | $0.80 | -10,240 | 792,695 | -1% | -$8,151 | ||||||
2024-05-03 | ALVR | Allovir, Inc. | Hagen Brett R | Chief Accounting Officer | S - Sale | $0.80 | -1,597 | 76,022 | -2% | -$1,271 | ||||||
2024-05-03 | ALVR | Allovir, Inc. | Sinha Vikas | See Remarks, 10% | S - Sale | $0.80 | -4,957 | 17,807,905 | 0% | -$3,946 | ||||||
2024-05-03 | ALVR | Allovir, Inc. | Miller Edward | GC | S - Sale | $0.80 | -2,311 | 509,715 | 0% | -$1,840 | ||||||
2024-05-07 | USNA | Usana Health Sciences Inc | Fuller Gilbert A | Dir | S - Sale | $44.59 | -490 | 0 | -100% | -$21,849 | ||||||
2024-05-03 | TWST | Twist Bioscience Corp | Banyai William | See Remark | S - Sale | $37.13 | -798 | 345,188 | 0% | -$29,633 | ||||||
2024-05-03 | TWST | Twist Bioscience Corp | Cho Dennis | See Remarks | S - Sale | $37.13 | -568 | 80,436 | -1% | -$21,092 | ||||||
2024-05-03 | TWST | Twist Bioscience Corp | Green Paula | SVP of HR | S - Sale | $37.13 | -910 | 91,511 | -1% | -$33,792 | ||||||
| D | 2024-05-03 | TWST | Twist Bioscience Corp | Leproust Emily M. | CEO | S - Sale+OE | $37.13 | -4,163 | 509,986 | -1% | -$154,589 | |||||
2024-05-03 | TWST | Twist Bioscience Corp | Werner Robert F. | Chief Accounting Officer | S - Sale | $37.13 | -132 | 43,548 | 0% | -$4,902 | ||||||
2024-05-03 | TWST | Twist Bioscience Corp | Finn Patrick John | Pres, COO | S - Sale | $37.13 | -2,311 | 173,895 | -1% | -$85,817 | ||||||
2024-05-06 | ETST | Earth Science Tech, Inc. | Saumat Giorgio R. | CEO, 10% | P - Purchase | $0.10 | +20,000 | 121,238,579 | 0% | +$1,900 | ||||||
| D | 2024-05-06 | CHD | Church & Dwight Co Inc /de/ | Price Penry W | Dir | S - Sale+OE | $105.47 | -7,752 | 27,262 | -22% | -$817,608 | |||||
2024-05-06 | AIM | Aim Immunotech Inc. | Equels Thomas K | CEO, Pres | P - Purchase | $0.41 | +61,729 | 778,184 | +9% | +$25,000 | ||||||
2024-05-06 | AIM | Aim Immunotech Inc. | Rodino Peter W III | COO, Secretary, Gen. Counsel | P - Purchase | $0.41 | +30,865 | 212,583 | +17% | +$12,500 | ||||||
| D | 2024-05-06 | PG | Procter & Gamble Co | Jejurikar Shailesh | COO | S - Sale+OE | $164.90 | -31,859 | 50,006 | -39% | -$5,253,549 | |||||
| D | 2024-05-02 | CORT | Corcept Therapeutics Inc | Lyon Joseph Douglas | See Remarks | S - Sale+OE | $26.00 | -10,830 | 7,314 | -60% | -$281,580 | |||||
2024-05-02 | SRPT | Sarepta Therapeutics, Inc. | Murray Dallan | Chief Customer Officer | S - Sale | $140.00 | -3,635 | 18,125 | -17% | -$508,900 | ||||||
| D | 2024-05-02 | SLDB | Solid Biosciences Inc. | Ganot Ilan | Dir | S - Sale+OE | $10.33 | -462 | 123,708 | 0% | -$4,772 | |||||
| M | 2024-05-02 | CMPS | Compass Pathways Plc | Goldsmith George Jay | 10% | S - Sale | $8.64 | -56,766 | 7,892,307 | -1% | -$490,432 | |||||
| M | 2024-05-02 | CMPS | Compass Pathways Plc | Malievskaia Ekaterina | 10% | S - Sale | $8.64 | -56,766 | 7,892,307 | -1% | -$490,432 | |||||
2024-05-02 | ARWR | Arrowhead Pharmaceuticals, Inc. | Vakiener Victoria | Dir | S - Sale | $23.31 | -1,799 | 30,205 | -6% | -$41,935 | ||||||
| A | 2024-05-02 | USNA | Usana Health Sciences Inc | Macuga Daniel A. | Chief Communications Officer | S - Sale | $47.14 | -3,791 | 0 | -100% | -$178,717 | |||||
| D | 2024-05-02 | BPMC | Blueprint Medicines Corp | Landsittel Michael | CFO | S - Sale+OE | $105.00 | -10,000 | 47,286 | -17% | -$1,050,000 | |||||
| D | 2024-05-02 | BPMC | Blueprint Medicines Corp | Hurley Ariel | Principal Accounting Officer | S - Sale+OE | $103.88 | -1,834 | 14,913 | -11% | -$190,516 | |||||
2024-05-06 | EPIX | Essa Pharma Inc. | Virsik Peter | COO | S - Sale | $6.95 | -694 | 11,246 | -6% | -$4,823 | ||||||
| D | 2024-05-02 | ME | 23Andme Holding Co. | Hibbs Kathy L | Chief Administrative Officer | S - Sale+OE | $0.49 | -38,551 | 1,252,315 | -3% | -$19,048 | |||||
| D | 2024-05-02 | DNA | Ginkgo Bioworks Holdings, Inc. | Dmytruk Mark E. | See Remarks | S - Sale+OE | $0.85 | -47,806 | 925,400 | -5% | -$40,396 | |||||
| D | 2024-05-02 | DNA | Ginkgo Bioworks Holdings, Inc. | Coen Steven P. | See remarks | S - Sale+OE | $0.85 | -131,928 | 162,527 | -45% | -$111,479 | |||||
| D | 2024-05-02 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | EVP, GC | S - Sale+OE | $85.01 | -1,850 | 56,157 | -3% | -$157,269 | |||||
2024-05-02 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | S - Sale | $82.91 | -5,000 | 66,767 | -7% | -$414,550 | ||||||
| D | 2024-05-03 | UTHR | United Therapeutics Corp | Causey Christopher | Dir | S - Sale+OE | $259.91 | -2,240 | 4,185 | -35% | -$582,195 | |||||
| D | 2024-05-03 | UTHR | United Therapeutics Corp | Olian Judy D. | Dir | S - Sale+OE | $258.56 | -10,000 | 7,305 | -58% | -$2,585,601 | |||||
| D | 2024-05-03 | UTHR | United Therapeutics Corp | Sullivan Louis W | Dir | S - Sale+OE | $258.39 | -5,160 | 13,060 | -28% | -$1,333,285 | |||||
2024-05-02 | CARA | Cara Therapeutics, Inc. | Posner Christopher | Pres, CEO | S - Sale | $0.75 | -3,936 | 176,585 | -2% | -$2,952 | ||||||
| D | 2024-05-03 | HXL | Hexcel Corp /de/ | Suever Catherine A | Dir | P - Purchase | $68.33 | +400 | 17,430 | +2% | +$27,332 | |||||
2024-05-03 | WLK | Westlake Corp | Bender Mark Steven | EVP, CFO | S - Sale | $152.19 | -4,950 | 40,356 | -11% | -$753,341 | ||||||
| M | 2024-05-01 | TNGX | Tango Therapeutics, Inc. | Mva Investors, LLC | See remarks | S - Sale | $7.53 | -210,000 | 488,524 | -30% | -$1,580,850 | |||||
| D | 2024-05-03 | VKTX | Viking Therapeutics, Inc. | Zante Greg | CFO | S - Sale+OE | $74.69 | -66,756 | 174,854 | -28% | -$4,986,008 | |||||
2024-05-03 | AMGN | Amgen Inc | Grygiel Nancy A. | SVP, CCO | S - Sale | $313.09 | -2,117 | 9,983 | -17% | -$662,802 | ||||||
| D | 2024-05-03 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale+OE | $40.03 | -10,000 | 101,959 | -9% | -$400,260 | |||||
2024-05-03 | VRNA | Verona Pharma Plc | Rickard Kathleen A. | Chief Medical Officer | S - Sale | $1.96 | -36,248 | 2,621,552 | -1% | -$71,032 | ||||||
| M | 2024-05-01 | HLVX | Hillevax, Inc. | Kohli Aditya | Dir | S - Sale | $14.03 | -6,898 | 782,878 | -1% | -$96,770 | |||||
2024-05-01 | MRNA | Moderna, Inc. | Afeyan Noubar | Dir | S - Sale | $110.92 | -15,000 | 11,692,969 | 0% | -$1,663,855 | ||||||
| M | 2024-05-01 | DAWN | Day One Biopharmaceuticals, Inc. | Bender Jeremy | CEO | S - Sale | $17.87 | -79,211 | 1,686,326 | -4% | -$1,415,707 | |||||
| M | 2024-05-01 | DAWN | Day One Biopharmaceuticals, Inc. | York Charles N II | COO, CFO, Secretary | S - Sale | $17.88 | -60,461 | 217,293 | -22% | -$1,081,191 | |||||
| D | 2024-05-02 | DTIL | Precision Biosciences Inc | Scimeca Dario | GC, Secretary | S - Sale+OE | $10.32 | -272 | 5,680 | -5% | -$2,807 | |||||
| D | 2024-05-02 | DTIL | Precision Biosciences Inc | Smith J. Jefferson | Chief Research Officer | S - Sale+OE | $10.32 | -154 | 75,544 | 0% | -$1,589 | |||||
2024-05-03 | ETST | Earth Science Tech, Inc. | Saumat Giorgio R. | CEO, 10% | P - Purchase | $0.10 | +100,000 | 121,218,579 | 0% | +$10,350 | ||||||
| D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Moore John R | GC | S - Sale+OE | $18.91 | -1,956 | 3,252 | -38% | -$36,988 | |||||
| D | 2024-05-02 | DTIL | Precision Biosciences Inc | List Alan | Chief Medical Officer | S - Sale+OE | $10.32 | -290 | 4,488 | -6% | -$2,993 | |||||
| D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | S - Sale+OE | $18.91 | -2,157 | 35,230 | -6% | -$40,789 | |||||
| D | 2024-05-02 | DTIL | Precision Biosciences Inc | Amoroso Michael | Pres, CEO | S - Sale+OE | $10.32 | -1,526 | 13,772 | -10% | -$15,748 | |||||
| D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Officer | S - Sale+OE | $18.91 | -1,718 | 13,422 | -11% | -$32,487 | |||||
| D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Chief Scientific Officer | S - Sale+OE | $18.91 | -1,576 | 7,238 | -18% | -$29,802 | |||||
| D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | S - Sale+OE | $18.91 | -3,682 | 19,897 | -16% | -$69,627 | |||||
| D | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Koch Kevin | Pres, CEO | S - Sale+OE | $18.91 | -3,152 | 353,262 | -1% | -$59,604 | |||||
| DM | 2024-05-01 | RXRX | Recursion Pharmaceuticals, Inc. | Gibson Christopher | CEO | S - Sale+OE | $8.10 | -100,000 | 834,820 | -11% | -$810,000 | |||||
| D | 2024-05-02 | ACAD | Acadia Pharmaceuticals Inc | Schneyer Mark C. | EVP, CFO | S - Sale+OE | $16.94 | -3,503 | 32,053 | -10% | -$59,341 | |||||
| D | 2024-05-02 | ACAD | Acadia Pharmaceuticals Inc | Teehan Brendan | EVP, COO, Head of Commercial | S - Sale+OE | $16.94 | -3,477 | 42,133 | -8% | -$58,900 | |||||
| D | 2024-05-02 | ACAD | Acadia Pharmaceuticals Inc | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S - Sale+OE | $16.94 | -1,326 | 14,370 | -8% | -$22,462 | |||||
| D | 2024-05-02 | ACAD | Acadia Pharmaceuticals Inc | Davis Stephen | CEO | S - Sale+OE | $16.94 | -11,427 | 155,231 | -7% | -$193,573 | |||||
2024-05-02 | AVTE | Aerovate Therapeutics, Inc. | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S - Sale | $21.02 | -1,981 | 0 | -100% | -$41,631 | ||||||
| D | 2024-05-01 | AVTE | Aerovate Therapeutics, Inc. | Noyes Timothy P | CEO | S - Sale+OE | $20.34 | -11,357 | 0 | -100% | -$230,946 | |||||
| D | 2024-05-01 | ACLX | Arcellx, Inc. | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale+OE | $51.33 | -18,168 | 8,938 | -67% | -$932,557 | |||||
2024-05-01 | ANIP | Ani Pharmaceuticals Inc | Gassert Chad | SVP - CORP. DEV., STRATEGY | S - Sale | $66.62 | -20,000 | 282,905 | -7% | -$1,332,400 | ||||||
| M | 2024-05-01 | FRTX | Fresh Tracks Therapeutics, Inc. | Exploration Capital, LLC | 10% | P - Purchase | $0.92 | +164,897 | 1,272,723 | +15% | +$151,680 | |||||
| D | 2024-05-01 | FOLD | Amicus Therapeutics, Inc. | Campbell Bradley L | Pres, CEO | S - Sale+OE | $10.07 | -7,500 | 886,654 | -1% | -$75,524 | |||||
2024-05-01 | ASIX | Advansix Inc. | Kintiroglou Achilles B. | SVP, GC | S - Sale | $25.23 | -3,661 | 35,335 | -9% | -$92,367 | ||||||
| D | 2024-05-02 | NUVL | Nuvalent, Inc. | Miller Deborah Ann | GC | S - Sale+OE | $72.07 | -3,000 | 33,300 | -8% | -$216,203 | |||||
| DM | 2024-05-01 | UTHR | United Therapeutics Corp | Rothblatt Martine A | CHAIRPERSON, CEO | S - Sale+OE | $254.15 | -7,200 | 130 | -98% | -$1,829,903 | |||||
2024-05-02 | ARQT | Arcutis Biotherapeutics, Inc. | Moore Matthew Richard | SVP, Chief Business Officer | S - Sale | $8.74 | -4,681 | 145,505 | -3% | -$40,902 | ||||||
| D | 2024-05-01 | STOK | Stoke Therapeutics, Inc. | Ticho Barry | Chief Medical Officer | S - Sale+OE | $11.37 | -10,000 | 2,485 | -80% | -$113,653 | |||||
2024-05-02 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks | S - Sale | $8.74 | -13,783 | 1,091,890 | -1% | -$120,433 | ||||||
2024-05-02 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | S - Sale | $8.74 | -5,016 | 185,408 | -3% | -$43,829 | ||||||
2024-05-02 | ARQT | Arcutis Biotherapeutics, Inc. | Burnett Patrick | See Remarks | S - Sale | $8.74 | -9,555 | 259,745 | -4% | -$83,490 | ||||||
| D | 2024-05-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GC, Corp Sec | S - Sale+OE | $61.74 | -1,667 | 30,597 | -5% | -$102,921 | |||||
2024-05-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $61.65 | -3,000 | 215,462 | -1% | -$184,942 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |